REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $374,000 | -43.3% | 113,250 | -50.4% | 0.00% | 0.0% |
Q2 2016 | $660,000 | -28.6% | 228,300 | +71.1% | 0.00% | -66.7% |
Q1 2016 | $925,000 | -22.7% | 133,450 | -2.8% | 0.01% | -25.0% |
Q4 2015 | $1,197,000 | +29.8% | 137,250 | -2.6% | 0.02% | +33.3% |
Q3 2015 | $922,000 | +88.2% | 140,950 | +215.3% | 0.01% | +100.0% |
Q2 2015 | $490,000 | +3.6% | 44,700 | +60.2% | 0.01% | 0.0% |
Q1 2015 | $473,000 | -25.5% | 27,900 | -29.5% | 0.01% | -14.3% |
Q4 2014 | $635,000 | +15.2% | 39,600 | -42.2% | 0.01% | +40.0% |
Q2 2014 | $551,000 | -4.5% | 68,500 | +7.0% | 0.01% | -37.5% |
Q1 2014 | $577,000 | +116.9% | 64,000 | +77.8% | 0.01% | +100.0% |
Q4 2013 | $266,000 | -8.9% | 36,000 | +16.1% | 0.00% | 0.0% |
Q3 2013 | $292,000 | – | 31,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |